Abstract: Parvulins belong to the family of peptidyl-prolyl cis/trans isomerases (PPIases) assisting in protein folding and in regulating the function of a broad variety of proteins in all branches of life. The human representatives Pin1 and Par14/17 are directly involved in processes influencing cellular maintenance and cell fate decisions such as cell-cycle progression, metabolic pathways and ribosome biogenesis. This review on human parvulins summarizes the current knowledge of these enzymes and intends to oppose the well-studied Pin1 to its less wellexamined homolog human Par14/17 with respect to structure, catalytic and cellular function.
Introduction
The topology of the native state of a protein is strictly correlated to its functional properties. To change these properties, e.g. owing to signaling stimuli, proteins often rely on posttranslational modifications (PTMs) and/or structural rearrangements. These molecular alterations have to be fast enough to allow the proper timely transmission of the signal in the cell. With respect to signal induced structural rearrangement only the unique functional state of the protein necessary to attain the adjacent process has to be selected and stabilized out of a multitude of available conformers in a reasonable period of time. Thus, isomer selective events, which are slow with respect to the subsequent coupled processes can become intrinsic bottle-necks of signaling transduction. The cis/trans isomerization of Xaa-Pro peptide bonds (Xaa being any proteogenic amino acid) turned out to be such a rate-limiting step in the structural rearrangement of proteins (Brandts et al., 1977) (Figure 1 ). As the relaxation times of cis/trans isomerization events in tertiary amides are about tenths to hundreds of seconds (Garel, 1980; Salahuddin, 1984) , natural enzyme catalysts have evolved that accelerate this process considerably. These enzymes are named peptidyl-prolyl-cis/trans isomerases (PPIases) (Lang et al., 1987; Fischer et al., 1989) . By enhancing cis/ trans isomerization PPIases act as molecular switches in functional activation or deactivation of enzymes and regulate protein-protein interaction in many cellular events (Fischer, 2000; Andreotti, 2003; Deber et al., 2007) . Owing to their important function, PPIases are represented in all domains of life. During evolution, PPIases have adopted various folds and topologies and are divided into different classes. The cyclophilins (CYPs) and FK-506 binding proteins (FKBPs) as well as the parvulins are known today Fanghänel and Fischer, 2004; Mueller and Bayer, 2008) , whereas the role of protein-Ser/Thr-phosphatase2A activator (PTPA) as representative of a new class of PPIases is still under discussion (Jordens et al., 2006; Magnusdottir et al., 2006) . The class of parvulins consists of proteins comprising catalytic domains of approximately 90-110 residues. The name parvulin is deduced from the Latin word 'parvulus' which means 'tiny' and is related to the low molecular mass of parvulins in contrast to the CYPs and FKBPs whose catalytic domains consist of much longer polypeptide chains (Rahfeld et al., 1994a) .
The first parvulin was discovered and purified from the organism Escherichia coli in the laboratory of Gunter Fischer (Rahfeld et al., 1994a,b) . Escherichia coli Par10 is a cytosolic 10.1 kDa protein of 92 amino acids whose catalytic activity could neither be inhibited by cyclosporin A nor by FK-506, the well-known inhibitors of CYPs and FKBPs. Thus, Fischer and coworkers assigned this protein to a new class of PPIases, the parvulins, to which they also assorted homologous protein sequences from bacterial species such as SurA, PrsA and PrtM. One year later a eukaryotic member, the protein Ess1, essential for growth in yeast (Hanes et al., 1989) , could be attributed to the parvulin class by sequence homology (Hani et al., 1995) . Shortly after, the human parvulin Pin1 was identified (Lu et al., 1996) as a protein interacting with the NIMA kinase, an enzyme essential for cell-cycle progression in Aspergillus nidulans. Pin1 could complement the function of Ess1 in yeast and turned out to regulate the escape from mitosis in cell-cycle transition (Lu et al., 1996) . The protein was demonstrated to act exclusively on phosphorylated Ser/ Thr-Pro moieties within a polypeptide chain (Ranganathan et al., 1997) . In 1999 the second human member, Par14 (eukaryotic homolog of parvulin, EHPF), a 14 kDa PPIase, was identified by a nucleotide Blast search by two groups independently Thorpe et al., 1999) . Par14 was found to have a poorly active catalytic domain and showed no preference for phosphorylated substrates . In contrast to Pin1, Par14 failed to rescue the loss of Ess1 in yeast (Metzner et al., 2001 ). Pin1 and Par14 homologs are found in all multicellular organisms and many unicellular eukaryotes. The number of parvulin representatives in most metazoans is limited to only one Pin1 and one Par14 homolog. In 2006 Müller and coworkers (Mueller et al., 2006 ) described a third parvulin species denoted Par17, an N-terminal extended version of Par14 that is exclusively expressed in hominids. Stick representation of trans-(left) and cis-(right) isomers of an Xaa-Pro-Pro + 1 moiety. Free energy differences are denoted by vertical arrows. ΔG ‡ = activation free energy differences; ΔG° = ground state free energy differences. Black: secondary amide; orange = tertiary amide.
Why is cis/trans isomerization of Xaa-Pro moieties such a remarkable process?
In amide bonds the lone pair nitrogen electrons are delocalized leading to a partial double bond character of the C′ i-1 -N i bond of the peptide unit. The amide bond represents a resonance hybrid (~40% double and ~60% single bond character). The resulting planarity of the peptide bond leads to the existence of two energetic minima with torsion angle values (ω = C α − C′ − N-C α ; rotation around the C′ i-1 -N i bond) of ω = 0° (cis) and ω = 180° (trans). The ΔG ‡ values of activation to overcome the rotational barrier between these two states are ~60-90 kJ · mol −1 depending on the chemical nature of the residues attached (Scherer et al., 1998; Schutkowski et al., 1998) and their corresponding ψ values (N − C α − C′-N) (Fischer et al., 1994; Hamelberg et al., 2005) . The barrier is about ~10-20 kJ · mol −1 lower for the cis-to-trans than for the trans-to-cis reaction. Hence, cis-to-trans isomerization rates are much faster (~1 s −1 ) than the rates for the reverse process (~10 −3 s −1 ). Steric and stereoelectric effects between the components of the peptide unit determine the difference in the ground state energy ΔG° of the cis and trans isomers (ΔG°≈10-17 kJ · mol −1 ) and, therefore, their populations within the dynamic equilibrium. These effects favor the transwith respect to the cis-conformation (Figure 1 ) (Barker and Boudreaux, 1967; Drakenberg et al., 1972; Scherer et al., 1998) . In consequence, the population of cispeptide bonds of secondary amides is less than 0.15% in polypeptides (Zhang and Germann, 2011) . In tertiary amides the presence of a proline moiety diminishes the energetic advantage of the trans-conformation (ΔG°≈4-7 kJ · mol −1 ), thus increasing the cis-isomer population with respect to the trans-conformers. In proteins cis-XaaPro populations are found to exist on average with about 5-6% probability and in smaller polypeptides with up to 30-40% (Stewart et al., 1990; MacArthur and Thornton, 1991; Milner-White et al., 1992; Weiss et al., 1998; Vitagliano et al., 2001) . The higher cis population found in tertiary amides with respect to those observed for secondary amides is correlated to slower cis-to-trans interconversion rates (~10 −3 s −1 ). Thus, forward and reverse reaction rate constants become comparable in Xaa-Pro moieties. In consequence, either cis-to-trans or trans-tocis interconversion can be rate limiting (Fischer, 2000) depending on the isomer required for a subsequent coupled process.
Genetics and expression of human parvulins
PIN1 expression is at low levels in most normal tissues, it is cell-cycle independent and mainly associated with cell proliferation (Bao et al., 2004) , whereas its expression is significantly enhanced in many human cancers (Ryo, 2003) . According to the Human Protein Atlas (HPA) PIN1 expression is highest in brain but also frequent in male and female reproductive tissues while it is low or absent in muscle (Uhlen et al., 2015) . The protein resides exclusively in the nucleoplasm of cells while cancer cells from gliomas and melanomas showed distinct nuclear and cytoplasmic expression.
Comprehensive tissue studies (see HPA) show highest expression of PAR14/17 in the gastrointestinal and urinary tract, kidney, gallbladder and liver as well as in the endocrinological and male reproductive systems, while lowest/ absent expression is found in skin, adipose and lymphatic tissues including spleen and the appendix. High and low expression transcripts of PAR14 were found within a brain transcriptome study (Hawrylycz et al., 2012) . According to the HPA HeLa and HepG2 cells displayed only protein in the nucleoli, whereas in cancer tissues hPar14/17 showed weak to moderate cytoplasmic and nuclear expression. Strong expression was observed in a few renal and ovarian cancers (see HPA). The chromosome locus of PAR14 gives rise to the expression of a second parvulin transcript caused by alternative transcription initiation (Mueller et al., 2006) , which generates a 25 amino acid N-terminally extended construct named hPar17. Although the PAR17 DNA sequence has evolved in the mammalian lineage, the necessary ATG start codon and correct reading frame for allowing proper transcription does only exist in hominids (Pongo, Gorilla, Pan, Homo) . An RT-PCR study showed low expression of PAR17 with respect to PAR14 in various human tissues. As Par17 includes all features of Par14 on the transcriptional and translational level, all former expression and localization studies on Par14 have to be reevaluated in the light of today's knowledge. An overview on the genetics and expression of human parvulins is found in Table 1 . The TATA-less promoters of PIN1 and PAR14/17, which are located within CpG islands point towards house-keeping genes, responsible for basal cell maintenance. Indeed, a survey for housekeeping genes (Eisenberg and Levanon, 2013) found PIN1 and PAR14/17 transcripts among its targets.
Structure of human parvulins
Bacterial and archaeal organisms have developed single domain parvulins (SDPs) consisting of only one domain (Lu et al., 1996; Uchida et al., 1999; Thorpe et al., 1999; Mueller et al., 2006 ) Promoter TATA-less and CAAT-less; contains 18 CpG islands, five of which are methylated Located within a CpG island; no TATAsequence (Mueller et al., 2006; Ferri et al., 2016) Transcription factors (TF) Under control of E2F, transcription can be enhanced via a BS1 side or suppressed by brain-selective AP4 n.d. Rustighi et al., 2009; Ma et al., 2012 ) Pseudogen PIN1L/PIN1P1 on Chr 1.q31.1; 89% identity by in-situ hybridization Chromosome 15; 97% sequence identity (to PAR14) (Campbell et al., 1997; Mueller et al., 2006 ) MW Protein 18.3 kDa 13.8 kDa 16.6 kDa (Lu et al., 1996; Uchida et al., 1999; Thorpe et al., 1999; Mueller et al., 2006 (Thorpe et al., 1999; Rippmann et al., 2000) , (Fujiyama-Nakamura et al., 2009; Kessler et al., 2007) ( Lederer et al., 2011) , although few multi-domain parvulins exist in these branches of life. In contrast, only few mere SDPs are expressed in eukaryotes (e.g. Pin1At) (Landrieu et al., 2000; Wang et al., 2010) . Instead, N-terminal extended SDPs or two-and multi-domain proteins are found even in the simplest unicellular organisms, e.g. trypanosomes (Erben et al., 2010) . Very often two or more parvulin representatives are expressed by eukaryotic cells -an evolutionary adaptation, certainly reflecting the complex compartmentation. The topology of the parvulin PPIase domain is highly conserved in all domains of life. In all eukaryotic branches studied so far, two functional subfamilies of parvulins emerged, one specific towards phosphorylated and the other towards non-phosphorylated substrates. Both subfamilies have developed specific sequential and structural adaptations with respect to substrate selection.
Sequence and secondary structure
The PPIase domains of the human members Par14 and Pin1 show ~35% sequence identity and more than 50% homology (Figure 2, ; bottom lines, sequence of Pin1 . Bottom, N-terminal domains and extensions: top line, sequence of Par14 ; middle line, sequence of Par17 -24-35 and bottom line, sequence of Pin1 . Sequences were aligned on the bases of residue similarity/identity and amino acids used for definition of the secondary structure elements were subsequently colored in blue (β-strand) and red (α-helix), as well as green (domain linker region). Background colors were used to highlight identical element positions in both proteins and the MTS (yellow). Secondary structural elements are denoted above or below the sequences. by 14 partly basic amino acids. In contrast, the second loop is extended in Par14 by six residues. β-strands 1, 2, 3 and 4 are very similar in length and composition. β 3 contains a short element that interrupts the strand geometry in both proteins (Sekerina et al., 2000) .
The N-terminal extension of Pin1 comprises the sequence of a WW domain (Lu et al., 1999b) , whereas Par14 and Par17 contain N-terminal stretches composed of mainly small or basic residues. Par14 and Par17 differ in their N-terminal extensions (Figure 2, bottom) , as an additional 25 residue mitochondrial targeting sequence is preceding the N-terminal extension in Par17. There are two coupled SNPs reported within the MTS sequence leading to a simultaneous exchange of amino acids at position −9 (Q > R) and −7 (R > S).
Tertiary and quaternary structure
The structure of hPin1 (1PIN) (Figure 3 ) co-crystallized with an Ala-Pro dipeptide (Ranganathan et al., 1997) was the first structure of a parvulin member. The Pin1 PPIase domain exhibits a core β-sheet element composed of four antiparallel strands opposing α-helix 3 ('gripping hand' topology). The catalytic center with the dipeptide bound in the cleft resides on the concave side of the β-sheet sheltered by the long loop between β 1 and α 1 . The side chains of the basic residues Lys 63 , Arg
68
, and Arg 69 therein encircle the negatively charged sulfate ion placed in direct proximity to the alanine of the Ala-Pro moiety (Figure 3) .
The WW-domain is mainly composed of a threestranded antiparallel β-sheet. , located in the β 1 -strand, mainly facilitates the coordination of the phosphate group (Schelhorn et al., 2015) (Figure 3, right) . Recent studies reported a binding preference towards Xaa-Pro-Pro motifs (Innes et al., 2013) . In contrast to the crystal structure, a highly dynamic interdomain interaction was observed in solution and in the cellular environment (Bayer et al., 2003; Jacobs et al., 2003) .
Three years after the first Pin1 structure was published, two groups reported the Pin1-related topology of hPar14 (1EQ3) elucidated by nuclear magnetic resonance (NMR) spectroscopy (Sekerina et al., 2000; Terada et al., 2001 ) (Figure 4 ). The structure of the PPIase domain of Par17 is expected to be identical to that of Par14. The alignment Top, comparison and overlay of the PPIase topology. Cartoon representation of the crystal structures of Pin1 (red; 1PIN) and Par14 (blue; 3UI4). Secondary structure elements are labeled; bottom, overlay of the catalytic centers. Left, amino acids that form the hydrophobic bottom hosting the proline residue. Right, residues of the hydrogen bonding network ('catalytic tetrad') and key amino acids responsible for substrate selectivity. Color code for residues: Par14, blue color; Pin1, red color.
of secondary structure elements and their overall threedimensional arrangement classifies the topology of parvulins to belong to the FKBP superfold. Pin1 and Par14 differ in the length of the loop regions between β 1 and α 1 (extended in Pin1) as well as between α 3 and β 3 (extended in Par14). Whereas the long basic loop in Pin1 is known to act in substrate binding and isomerization, the function of the extended loop in Par14 has not been investigated so far. The basic loop in Pin1 is hold into position by helix α 1 that is extended by two turns with respect to Par14. The topology of β 3 is interrupted either by the Asp (Sekerina et al., 2000; Terada et al., 2001 ) and owing to its high degree of PTM (Reimer, 2003) may be defined as an intrinsic disordered region (IDR) (van der Lee et al., 2014) . The mitochondrial targeting sequence (MTS) within the N-terminus of Par17 was predicted to be helical (Gor4, CFSSP) (Mueller et al., 2006) . This was not observed in an NMR study , which predicted a complete random coil state from Met 24 to Gly 35 from chemical shift assignment.
The catalytic center forms a deep cleft within the molecular surface of human parvulins. The positioning of identical and homologous amino acids within the catalytic cleft is spatially conserved among Par14 and Pin1 (Figure 4 . Par14 exhibits two bulky hydrophobic residues (Val 91 and Phe 120 ) where Pin1 carries charged/polar residues (Gln 131 and Ser 154 ). The polar and hydrophobic characters of these two positions are strongly conserved throughout the subfamilies of phosphorylated and non-phosphorylated substrate specific parvulins. They are likely to be key residues for substrate specificity (Figure 4 bottom, right) (Vohringer-Martinez et al., 2012; Mercedes-Camacho et al., 2013; Velazquez and Hamelberg, 2013) .
Pin1 and Par14 differ in their surface topologies ( Figure 5 ). Whereas the catalytic cavity is surrounded by conserved hydrophobic amino acids in both parvulins, the positions of basic residues within the β 1 -α 1 loop in Pin1 are taken by residues carrying hydrophobic and acidic side chains in Par14. Opposite of the catalytic center both parvulins possess a putative protein interaction site. In case of Pin1, this site is a flat hydrophobic interface surrounded by Glu 
Catalytic mechanism
A first insight into the mechanism of cis/trans isomerization by parvulin proteins results from a crystallographic study of Pin1 in complex with an Ala-Pro peptide (Ranganathan et al., 1997 . The authors also brought evidence for the functional importance of this network within the catalytic process by a mutagenesis study. However, no further progress was achieved in supporting the nucleophilic attack by Cys 113 experimentally. Based on a biochemical study Litchfield and coworkers suggested an alternative non-covalent mechanism where the (partial) negative charge of Cys 113 in Pin1 prevents the sp 3 -hybridization of the carbonyl oxygen (Behrsin et al., 2007) . In their model, the negative charge of the sulfhydryl group helped to stabilize the double bond character of the carbonyl oxygen atom and subsequently the single bond character of the amide bond. This assumption would also explain the efficient catalytic properties of conserved aspartate residues in parvulins lacking a cysteine at this position. In a series of publications, Felicia Etzkorn and her coworkers finally verified the non-covalent mechanism. They used transition state inhibitors (Xu et al., , 2012 of Pin1 to confirm a twisted amide ω-90°-syn-exo transition state conformation (Mercedes-Camacho et al., 2013) . Based on these measurements a transition state was proposed that is stabilized by an intramolecular hydrogen bond from the amide Pro +1 to the prolyl nitrogen ( Figure  6 ). This transition state seems to be stabilized and preferentially bound by the enzyme which thereby diminishes the rotational activation barrier (Greenwood et al., 2011; Velazquez and Hamelberg, 2013) . As observed in other structural models (Ranganathan et al., 1997; Zhang et al., 2012) , the proline ring resides within a hydrophobic pocket formed by the conserved residues Leu 122 , Met 130 and Phe
134
.
These and other conserved hydrophobic residues and their side-chain flexibilities seem to play an important role in catalysis and substrate binding (Labeikovsky et al., 2007; Namanja et al., 2007) . Subsequent quantum/molecular mechanics (QM/MM) calculations supported the experimental data (Vohringer-Martinez et al., 2012 , 2014 and gave a more detailed analysis of single residues participating in the cis-to-trans and trans-to-cis catalysis steps. These cis/trans isomerization mechanism requires the hydrogen bond network of the 'catalytic tetrade' (Velazquez and Hamelberg, 2013) ) are important anchor points for the occurring bond rotations in the isomerization step. Triade and phosphate group in reverse determine the substrate specificity of phosphate specific parvulins such as Pin1. How the twisted-amide mechanism and substrate specificity is realized in non-phosphate specific parvulins such as Par14/17 lacking these anchor points awaits elucidation. As the twisted-amide mechanism was also demonstrated to underlie the catalytic cis/trans reaction in other PPIase families (Hur and Bruice, 2002) it is generally accepted for parvulins today.
Specificity of human parvulins
The k cat /K M value is generally used to determine the effectiveness of cis/trans isomerization. As the activation barrier for the cis to trans rotation differs from that of the Filled circles denote carbon (black) and heteroatoms (oxygen = red; nitrogen = blue; phosphorus = yellow). Dotted lines indicate residues preceding and following the pSer-Pro moiety. In the trans conformation the hydrogen bond from Ser 154 switches from the phosphorus group to the prolyl bond carbonyl group which then gets rotated closer to the serine side chain oxygen (light green).
reverse process, k cat /K M values are path-dependent specific constants.
Measuring specificity of PPIases
An elegant method to determine the specificity constants for the cis to trans isomerization was introduced in 1984 (Fischer et al., 1984) and later improved (Kofron et al., 1991) . The constants are measured at low temperature adding a (cis-state locked) chromophore-tagged (e.g. p-nitroanilide) model peptide to a solution of α-chymotrypsin. As this enzyme is a trans-specific protease with fast reaction kinetics, it leaves only the cis population uncleaved. The relative slow cis to trans interconversion acts as a rate limiting step providing a first-order kinetics. This kinetics is accelerated when a PPIase is present. Kinetics can be followed by the increase in absorbance at 405 nm upon cleavage of p-nitroanilide. In addition, NMR methods have been designed that enable a temperature dependent and tag-free determination of the path-dependent k cat /K M values (Hsu et al., 1990; Justice et al., 1990) . Both values can be determined simultaneously by recording exchange spectroscopy experiments with increasing mixing time (Kern et al., 1995; Greenwood et al., 2011) followed by line-shape analysis. All versions of these assays have been used to measure the specificity constants of parvulins, especially for the phosphate-specific Pin1.
Specificity of hPin1
The first hint for a pSer/pThr-Pro specificity of hPin1 arise from the assessment of the crystallographic structure of the protein (Ranganathan et al., 1997) . The binding of a sulfate ion within the catalytic cleft between a co-crystallized substrate analogue and the basic loop region was interpreted in terms of a missing phosphoryl group at the substrate peptide. Inspired by this idea, the authors could show a more than 100-fold preference of the phosphateserine mimetic glutamate over a glutamine in the Pro-1 position of a model substrate in an activity assay. The hypothesis of a phosphate dependent PPIase was finally verified using different phosphorylated and non-phosphorylated model substrates in conjunction with Pin1 constructs carrying mutations within the catalytic center and the basic loop region (Yaffe et al., 1997) . The k cat /K M values were in the range of 1000-4000 mm −1 s −1 (pThr-Pro) as well as 3000-20 000 mm −1 s −1 (pSer-Pro). As verified by other groups these values are up to more than 1000 times higher than the k cat /K M values for the corresponding nonphosphorylated substrates (Rippmann et al., 2000; Fanghanel et al., 2006) . The specific activity of endogenous Pin1, is reduced by a factor of 4-9 in lysates of investigated organs (Fanghanel et al., 2006 ). This pointed towards a possible inhibition or regulation of Pin1 activity in vivo.
Specificity of hPar14
Upon the discovery of Par14, Uchida and coworkers detected minor activity against a model peptide in the protease coupled assay. Par14 exhibits specificity constants in the range of m −1 s −1 for these substrates, which are more than 1000 times lower than those measured for Pin1 in the presence of phosphorylated substrates. The highest activities were observed for substrates with arginine or leucine residues preceding the proline. However, the specificity constants for such Arg-Pro containing model substrates are only about 25 times higher when compared to His-Pro containing peptides, the substrates with the lowest hitherto measured specificity constants. This low selectivity is in agreement with observations of substrate selectivities found for other non-phosphate specific parvulins (e.g. E. coli Par10) . hPar14 also catalyzes Ser-Pro moieties of model substrates with specificity constant values similar to those of Arg-Pro containing peptides (preliminary data measured by the authors of this review for the PPIase domain of hPar14).
Recently, a strong analogy of substrate selectivity between Par14 and Nitrosopumilis maritimus and Cenarchaeum symbiosum PinA was reported (Hoppstock et al., 2016) pointing towards a putatively evolutionary conserved substrate spectrum found in non-phosphate specific parvulins (Table 2 ). However, this hypothesis still suffers from an insufficient number of measured specificity constants for different parvulins.
Cellular functions
Proline isomerization conveys substantial conformational changes into targeted proteins and these changes happen on a second to hour time scale. Hence, cis/ trans isomerization is in general too slow to be used for regulating protein-dependent cellular processes, which occur on time scales more than a thousand-times faster -within the range of milliseconds (Velazquez, 2014) . PPIases accelerate isomerization and this way enable this process to compete with reactions responsible for cell fate decisions such as PTMs or protein-proteininteractions. This is exactly what defines the role of human parvulins in the cell. Selectivity of substrates is either gained by the structural organization of the catalytic center and its surrounding residues, or, moreover, by specialized N-terminal domains or extensions that act as binding modules for a defined set of substrates. These domains/extensions relocate the catalytic domains to the proper location and deliver it to selected biomolecule complexes. Finally, the concerted action of all domains creates the high selectivity and specificity of parvulins towards their protein targets in the cellular environment.
The cellular function of hPin1 in a nut-shell
The elucidation of the cellular function of hPin1 was initiated and is still pushed on by the lab of Kun Pin Lu (Lu et al., 1996 . Since the discovery of hPin1, many excellent studies and reviews have been published focusing on this topic by various labs (Zhou et al., 1999; Shaw, 2002; Lu and Zhou, 2007; Yeh and Means, 2007; Liou et al., 2011; Lin et al., 2015; Nakatsu et al., 2016) . Owing to the fast growing number on Pin1 publications, only some important aspects of Pin1's cellular function are summarized below. Pin1 plays a unique role in cell division. It was the first prolyl isomerase identified that is involved cell cycle progression (Lu et al., 1996) . Its pronounced, but not exclusive role in mitosis is illustrated by remarkable observations. The protein recognizes most epitopes within phosphoproteins that are detected by the mitotic phosphoprotein specific antibody MPM-2 (Yaffe et al., 1997) and is essential for initiation as well as progression of mitosis (Lu et al., 1996) , but is active in all phases of the cell cycle (Lin et al., 2015) . Knockdown/Knockout of hPin1 in fast dividing cells, such as cancer cells, leads to mitotic arrest and apoptosis (Lu et al., 1996; Rippmann et al., 2000) , while addition of Pin1 to Xenopus extracts or overexpression in human cell lines leads to inhibition of G2/M transition (Lu et al., 1996; Crenshaw et al., 1998; Shen et al., 1998) . Despite its unique role in the cell cycle, Pin1 is not essential for survival in metazoan organisms (Maleszka et al., 1996; Fujimori et al., 1999; Liou et al., 2002) , while it is crucial for most representatives of unicellular unikonts such as the ascomycetes, saccharomyces, candida and aspergillus/emericella (Hanes et al., 1989; Lu et al., 1996; Devasahayam et al., 2002; Joseph et al., 2004) .
When focusing on the cellular function of Pin1, it is better to discuss the common hallmarks featured by proteins that act as substrates of the PPIase rather than to itemize each single interaction partner. hPin1 substrate proteins need to exhibit an accessible Ser/Thr-Pro motif that resides in sequence regions which are recognized and subsequently phosphorylated by Pro-directed kinases . Once the pSer/pThr-Pro motif has been created hPin1 can either compete for it with phosphate specific regulators or Pro-directed phosphatases (Xu et al., 2003) or can supply isomer specific regulators/phosphatases with the proper cis/trans conformation. Indeed, conformer specific phosphatases which either prefer motifs in trans-form, such as PP2A (Zhou et al., 2000) , or in cis-form, such as Ssu72 (Werner-Allen et al., 2011) exist. The respective substrate proteins of these phosphatases Cdc25, Tau (Zhou et al., 2000) or the C-terminal domain of RNA-PolII (Albert et al., 1999; Xu et al., 2003) were among the first cellular targets found for Pin1. Considering these short motifs, one may expect a vast orchestra of different phosphatase and kinase substrates among the target proteins of hPin1, which is obviously the case (Liou et al., 2011; Zhou and Lu, 2016) . As the interaction of hPin1 with a certain substrate protein is in general either facilitating or inhibiting dephosphorylation (Zhou et al., 2000; Yu et al., 2006) , isomerization enables or prevents subsequent reactions and, thus, determines the fate of the protein. Subsequent reactions are often the initiation or prevention of PTM processes such as ubiquitination (Siepe and Jentsch, 2009) or conformer-specific protein-protein interactions . Depending on this outcome Pin1 could enhance (Lee et al., 2009b) or weaken Eckerdt et al., 2005; Luo et al., 2010; Khanal et al., 2012) protein stability and influence protein turn-over; it can drive protein cascades in signaling events (Keune et al., 2013; Toko et al., 2013; Antonelli et al., 2014; So and Oh, 2015; Rustighi et al., 2017) or regulate metabolic processes such as the insulin dependent glucose uptake (Nakatsu et al., 2009) .
A mechanistic view on hPin1 cellular function
One important factor to be considered in the cellular function of hPin1, is the role of the WW-domain. It transports the PPIase to the cellular nucleus, dominates localization in nuclear speckles (Rippmann et al., 2000) and, thus, limits the putative substrates to a certain number of nuclear proteins (Lu et al., 1999b) . The WW-domain is specific against a set of binding motifs similar to those known to be isomerized by the catalytic domain (Lu et al., 1999b; Schelhorn et al., 2015) , although certain differences have been implied recently (Innes et al., 2013) . The affinity of such target motifs is a few times higher to the WW domain than to the PPIase domain (Lu et al., 1999b) . Hence, on the one hand the WW-domain is able to target the same motifs as the catalytic domain does (Schelhorn et al., 2015) , but on the other hand, the WW domain can select and bind a special motif, thereby guiding hPin1 to a nearby second targeting side amenable for its catalytic domain . The latter mechanism is supposed for multiphosphorylated target proteins such as the RNA-PolII (Kops et al., 2002) or Tau (Smet et al., 2005) .
In contrast to the above models, the WW-domain may also exclusively bind a target motif without isomerizing the substrate. In this case, the action of Pin1 would be independent of its catalytic functions. Such a behavior, has been observed for the regulation of the AF-1 domain of the nuclear receptor PPARγ (Fujimoto et al., 2010) and for the Creb-regulated transcriptional coactivator 2 (Nakatsu et al., 2010b) .
A third scenario can be pointed out (Ubersax and Ferrell, 2007) by analogy to the two domain polo-like kinase 1 (Plk1) (Elia et al., 2003) . In line with this model the WW-domain of Pin1 may be able to inhibit the activity of its neighboring PPIase domain until a kinase with specificity to a consensus sequence similar to that of the WW-domain/PPIase domain would prime a substrate for further regulation by Pin1 catalytic domain. Upon binding of the WW-domain to its primed substrate, the PPIase would be released and activated. Indeed, inter-domain interaction within Pin1 (Bayer et al., 2003; Jacobs et al., 2003) and an influence of substrate binding on the domain interface (Namanja et al., 2011) have been demonstrated. Furthermore, a negative allosteric regulation of the activity of Pin1 upon inter-domain contact has been reported . The affinity of Pin1 towards substrate ligands, which is mainly attributed to the binding affinity of the WW-domain, is enhanced during inter-domain contact (Matena et al., 2013) . However, these in-vitro data still have to be validated for the in vivo behavior of hPin1.
PTM of hPin1
The first PTM described for Pin1 was a phosphorylation on its WW-domain at Ser 16 by protein kinase A (PKA) . It diminished the protein's ability to bind to its substrates, but assures mitotic progression. This finding is in agreement with a recent observation ) that Aurora A is also capable of phosphorylating Ser 16 thereby suppressing the function of Pin1 within the G2/M phase. However, Ser 16 modification seems not always to have negative regulating effects on Pin1. In contrast, phosphorylation of this residue through the MAP3K-related serine-threonine kinase COT led to a more enhanced stabilizing function of the protein on cyclin D1 (Kim et al., 2015) . In the same manner phosphorylation at Ser 16 by the ribosomal protein S6 kinase alpha-3 (Rsk2) enhances Pin1 dependent cell transformation (Cho et al., 2012) .
Phosphorylation at the PPIase domain at Ser 65 by the Plk-1 has been described to enhance protein stability by preventing ubiquitination and subsequent proteasomal degradation of Pin1 (Eckerdt et al., 2005) . PTMs, which influence the catalytic activity of Pin1, have only very recently been discovered. In 2011 Lee and coworkers reported phosphorylation at Ser 71 by the tumor suppressor protein death-associated protein kinase 1 (DAPK1). It inactivates Pin1 catalytic activity and prevents nuclear location. Only 1 year later an increased PPIase activity and pronounced nuclear translocation have been described upon phosphorylation of Pin1 by MLK3 kinase on Ser 138 (Rangasamy et al., 2012) . A few months later it was shown that Pin1 can be sumoylated at lysines 6 and 63 and that this lowers the ability of the protein to interact with its known substrate binding sites . Moreover, these PTMs decreased Pin1 catalytic activity and abolished its cellular function. In reverse, these activities could be restored upon desumoylation by SENP1. The PTMs occurring on Pin1 are summarized in Figure 7 .
The cellular function of hPar14 is regulated by PTM
In early protein sequence based analyses conserved DNA binding motifs were identified in Par14 Surmacz et al., 2002) . In consequence, Surmacz and coworkers demonstrated the binding of Par14 to bent A-tract motifs of double strand DNA oligonucleotides as well as to DNA-sepharose in vitro. They proved the N-terminus of the protein to be responsible for highaffinity DNA binding and essential for entry into the cellular nucleus. In vivo phosphorylation of the N-terminal residue Ser 19 by casein kinase 2 abolished the DNA-binding capability . Whereas a Ser Glu phosphate mimic mutant does not only restore this function, but even shifts the cytoplasmic/nuclear ratio of the protein to a complete nuclear location . In the nucleus dephosphorylated Par14 associates with chromatin (Saningong and Bayer, 2015) and co-localizes to B23 in the nucleolus (Fujiyama-Nakamura et al., 2009) , where it associates to pre-ribosomal ribonuclear protein (pre-rRNP) complexes (Fujiyama et al., 2002; Fujiyama-Nakamura et al., 2009) . The interaction of Par14 with these complexes as well as its activity depend on the presence of the unstructured N-terminal extension. Par14 resides in the pre-rRNP complexes with a series of cellular trans-acting factors such as rDNA transcription factors, RNA-binding proteins, RNA-helicases and RNA modifying proteins. In those complexes Par14 acts as a novel rRNA processing factor. Knockdown of Par14 mRNA decelerates the processing of pre-rRNA to 18 and 28 S rRNA, demonstrating an essential role of the protein in ribosome biogenesis (Fujiyama-Nakamura et al., 2009) . Although ribosome biogenesis is mainly assigned to the G1 phase of the cell cycle (Donati et al., 2012) , Par14 expression is enhanced in the S as well as in the G2/M phase (Saningong and Bayer, 2015) suggesting a more pronounced function in DNAreplication, DNA repair and/or chromatin remodeling. The nuclear export of Par14 requires phosphorylation of Ser 7 and Ser 9 by the PKB/Akt kinase (or PKC) and is maintained by 14-3-3 protein in a Crm1 dependent way (Reimer, 2003) . 14-3-3 binds to Ser 7 and Ser 9 and induces cytoplasmic localization of Par14, which may probably silence the protein's function or may initiate its proteasomal degradation (Figure 8 ). Cytoplasmic Par14 interacts with the insulin receptor substrate (IRS-1) (Zhang et al., 2013a) , enhances insulin-induced tyrosine-phosphorylation of IRS-1 and strengthens its interaction with PI3 kinase, but also increases Ser/Thr phosphorylation of PKB/Akt kinase. During mitosis Par14 associates to the spindle apparatus (Fujiyama-Nakamura et al., 2009) .
Three different phosphate-proteomic screens found phosphorylation on Tyr 122 within Par14 upon the stimuli of the receptor tyrosine kinases FGFR1/3 and CSF-1R by their ligands (Kasyapa et al., 2009; St-Germain et al., 2009; Knowlton et al., 2010) . The influence of this PTM on the structure and function of hPar14 remains elusive. Phosphorylation does not seem to be the only PTM of Par14/17 (Figure 7 below), as a putative acetylation motif in the N-terminus of the protein (Surmacz et al., 2002) was also described. Acetylation within this motif at position Lys 6 and Lys 11 is reported by PhosphositePlus (Hornbeck et al., 2015) . In addition, acetylation of the more distant Lys 32 was found in a comprehensive MS/MS study (Choudhary et al., 2009 ).
The cellular function of hPar17
Most experiments that have been done to elucidate the function of Par14 do not discriminate between the protein and its extended version, Par17. Therefore, the above cellular functions assigned to Par14 may have partly to be attributed to Par17 instead. Recombinant Par17 can be transported to the inner mitochondrial matrix in a membrane potential dependent manner (Kessler et al., 2007) . The N-terminal extension seems to act as a mitochondrial targeting and import sequence (MTS). In-vitro Par17 is able to bind to DNA (Mueller et al., 2006) and to catalyze tubulin polymerization (Thiele et al., 2011) in a calcium ion and calmodulin dependent manner (Burgardt et al., 2015) . Tubulin polymerization is the only yet reported event depending on the catalytic activity of Par14/17. Less is known about regulation and modification of Par17, but a 28 kDa species was identified and observed in several studies (Surmacz et al., 2002; Reimer et al., 2003; Kessler et al., 2007) . Although this species reacted with a Sumo2/3-antibody (Kessler et al., 2007) , the protein was not found as sumoylated species in comprehensive proteomic screens (Hendriks and Vertegaal, 2016) .
Is there a cross-talk between human parvulins?
Pin1 is essential for mitotic progression in most unikont organisms, but gene disruption in metazoan and fission yeast results in viable organisms. Fujimori and coworkers created Pin1 knockout mice and showed that this parvulin is not essential for cell proliferation . However, in a follow up study it was demonstrated that Pin1 −/− embryonic fibroblasts (MEFs) grew slower than the corresponding control cells and entered an irreversible G0 state upon serum starvation (Uchida et al., 2003) . This restricted growth of Pin1 −/− MEFs points towards a compensating mechanisms. The authors suggested that other PPIases can probably partially compensate for Pin1 in growing cells. As functional compensation for Ess1/ Pin1 by cyclophilins A was observed in yeasts Huang et al., 2001) , and the most differentially up-regulated gene/protein in Pin1 −/− MEFs was Par14, the second human parvulin representative turned out to be a likely candidate for overcoming the loss of Pin1. This idea was supported by the fact that siRNA depletion of Par14 inhibits the growth of Pin1 −/− MEF and inhibitors designed for acting on both parvulins increase the amount of S-phase cells in synchronized cell lines (Uchida et al., 2003) . Moreover, Pin1 and Par14 have been found to be active in similar cellular events and pathways as summarized in Table 3 . These are indications, that there might be a cross-talk of both parvulins. However, the detailed cellular processes underlying such a putative cross-talk and the mechanistic interplay between the proteins remain elusive. The scheme is based on data from (Surmacz et al., 2002; Reimer, 2003; Reimer et al., 2003; Fujiyama-Nakamura et al., 2009; Zhang et al., 2013a) . Red filled circles indicate phosphorylation sites. IRS-1 = insulin receptor substrate 1; PKB = phosphokinase B, also known as Akt; CK2 = casein kinase 2, RTK = receptor tyrosine kinase; PI3K = phosphatidylinositol-4,5-bisphosphate 3-kinase kinase; Crm1 = chromosomal maintenance 1, also known as Exportin 1 (XPO1); cytoplasm (gray) and nucleoplasm (pink) are colored. Parvulin (blue bar) and 14-3-3 protein (light green rounded rectangle).
Related diseases
As Pin1 regulates cell-cycle progression it is involved in a broad variety of diseases that are correlated with unbalanced expression levels of the protein. Depending on which type of cell is affected by Pin1, the protein is observed to play an essential role in tumorigenicity, immune response, aging and dementia, microbial infection as well as the metabolic syndrome. In contrast, less is known about the involvement of Par14/17 in human pathology (Figure 9 ).
Pin1 is involved in dementia and neuronal diseases
Differences in the degree of promoter methylation and changes in the expression levels of Pin1 in the brain were correlated with frontotemporal dementia (FTD), Alzheimer's disease (AD) (Wijsman et al., 2004; Sultana et al., 2006; Segat et al., 2007; Ferri et al., 2016) as well as corticobasal degeneration (Hutton et al., 2001) and Parkinson disease (PD) (Ghosh et al., 2013) . Pin1 works as a proapoptotic factor in degeneration of dopaminergic neurons and was shown to co-localize with Lewy-body fractions obtained from human PD brain tissues. In addition, Pin1 facilitates the formation of α-synuclein inclusions (Ryo et al., 2006) . In AD neurofibrillary tangles are formed, being composed of hyper-phosphorylated tau protein (p-tau). Normally, more than 90% of phosphorylated p-tau peptides are in trans conformation (Lim et al., 2008) . Cis p-tau was found to be a precursor of tau pathology and an early driver of neurodegeneration in AD. Pin1 protects against tau-aggregation by isomerizing p-tau and (Butterfield et al., 2006) by regulating tau dephosphorylation (Lu et al., 1999a . Pin1 also slows down the amyloidogenic Aβ production from amyloid precursor protein (APP) (Pastorino et al., 2006) . Cys 113 was found to be sensitive to oxidation by increased reactive oxygen species found in AD patients thereby losing the protein's catalytic activity upon tau protein (Sultana et al., 2006; Chen et al., 2015; Innes et al., 2015) . In summary, all events leading to a down-regulation of Pin1 in brain boost the likelihood of AD onset (Butterfield et al., 2006) . Despite Pin1 up-regulation processes delay AD onset (Ma et al., 2012) they may increase the risk and early onset of frontotemporal atrophy (Lim et al., 2008; Ferri et al., 2016) . Very recently low expression levels of Pin1 have been found in the brains of patients suffering from temporal lobe epilepsy (Tang et al., 2017) .
Pin1 is involved in the metabolic syndrome
Under high fat diet (HFD) feeding of mice Pin1 contributes to glucose metabolism, to bone formation and the maintenance of vascular functions like in the development of metabolic syndromes (Nakatsu et al., 2011; Lu et al., 2013; Lee et al., 2014b; Han et al., 2016) . Highly increased Pin1 levels induce the onset of obesity, the nonalcoholic fatty liver disease, diabetes mellitus and atherosclerosis (Nakatsu et al., 2011 (Nakatsu et al., , 2012 Lu et al., 2013; Paneni et al., 2015) . Additionally, Pin1 has a biphasic effect on the insulin receptor substrate pathway (Saltiel and Kahn, 2001) . Under normal conditions, Pin1 binds the IRS-1 and enhances the insulin signaling, leading into an increase of glucose uptake. But under HFD conditions Pin1 causes insulin resistance and a decrease in glucose uptake (Lee et al., 2009a; Park et al., 2012) .
Pin1 regulates the immune response and is involved in viral infection
Pin1 modulates the immune response in general by regulating the NFkB signaling pathway . The Table 3 : Similar pathways and events influenced by human parvulins.
Pin1
Par14/17 Reference Targets in G2/M phase and S-phase Highest expression in G2/M phase and S-phase (Saningong and Bayer, 2015; Lu et al., 1996) IRS-1 dependent signaling IRS-1 dependent signaling (Zhang et al., 2013a; Nakatsu et al., 2009; Nakatsu et al., 2010a ) Splicing of RNA Involved in RNA processing (Xu et al., 2003; Fujiyama-Nakamura et al., 2009 ) Tubulin stabilization Tubulin polymerization (Lu et al., 1999b; Thiele et al., 2011 ) Located in nuclear speckles Located in nucleolus (Par14) (Rippmann et al., 2000; Fujiyama-Nakamura et al., 2009 ) Interaction with CK2
Interaction with CK2 Messenger et al., 2002 ) Modulating GSK3b in brain Putative modulation of GSK-3b via pAkt Zhang et al., 2013a; Blair et al., 2015) protein is involved in asthma development (Esnault et al., 2008) . Additionally, Pin1 regulates key steps of viral life cycles. It contributes to the uncoating of the HIV-1 core, the reverse transcription of the RNA genome and the integration of the HIV-1 cDNA into chromosomes. Hence, inhibition of Pin1 leads to an attenuation of HIV-1 replication. Pin1 could also possibly promote HIV-1 infection (Hou et al., 2015) . Silencing of Pin1 expression leads to a decrease in hepatitis C virus (HCV) replication, whereas overexpression resulted in an increase of HCV replication (Lim et al., 2011) .
Pin1 is involved in tumorigenesis and cancer
Increased expression levels and activated forms of Pin1 are correlated with various forms of cancer Ayala et al., 2003; Pang et al., 2007; Xu and Etzkorn, 2009; Luo et al., 2015; Shi et al., 2015; Min et al., 2016) . The protein is able to inactivate tumor suppressors and to activate up to 42 oncogene/growth-promoting regulators (Cheng et al., 2013; Wei et al., 2015) . The expression of Pin1 in cancer cells is regulated by different micro RNAs (Zhang et al., 2013b; Lee et al., 2014a) . Lower expression levels may lead to a decreased risk of cancers like in the case of the single-nucleotide polymorphism (SNP) 842G > C (rs2233678) (Lu et al., 2009; Li et al., 2013) .
Par14/17 related diseases
Par14 downregulation is correlated to primary biliary cirrhosis (PBC), an autoimmune chronic cholestatic liver disease, leading to choleostal fibrosis and cirrhosis (Mitchell et al., 2011) . As this disease is thought to have epigenetic origin, a role of Par14 in chromatin-remodeling processes is suggested. Par14 was found in the exosomes produced from K-RAS collateral cancer cells (Demory Beckler et al., 2013) . In the latter Par14 was among the group of proteins with significantly different exosomal levels. Thus, the protein may contribute to this higher invasiveness of recipient cells (Higginbotham et al., 2011) .
Inhibitors
As Pin1 plays an important role in several cellular pathways and its upregulation and/or high activity is related to a broad range of cancers, to metabolic disorders and microbial infection it became an interesting drug target (Table 4) . Specific inhibitors for Par14 are missing. To our knowledge only the cell-permeable tetra-oxobenzo-phenanthroline inhibitors designed by Uchida and coworkers (Uchida et al., 2003) efficiently block PPIase activity of Pin1 as well as Par14 with comparable IC 50 values of ~1 μm in a PPIase assay. (Hennig et al., 1998) Pepti-cinnamine analogue 1 (PA1) 0.6 In cells Attacks and adds covalently to cysteine and /or lysine side chains;
Designed on the basis of the inhibitor pepti-cinnamin C; selective (Bayer et al., 2005) Diethyl- 1,3,6, 8-tetrahydro-1,3,6,8-tetra-oxobenzo[lmn] 3 and 8 phenanthroline-2,7-diace-tate (PiB)
In vitro
In cells Acts by blocking cell cycle progression; also inhibits Par14 activity in a PPIase assay (Uchida et al., 2003) (Wei et al., 2015) Aryl hetaryl ketones and thioketones (here: 11e)
1

In vitro
The compounds might mimic the transition State of the enzymatic conversion (Hediger et al., 2012) KPT-6566
In cells In animal model -Is able to selectively inhibit Pin1 and targets it for degradation -It binds covalently to the catalytic site of Pin1 Small molecule with unknown mechanism Cyclohexyl ketone Inhibitors -- (Xu et al., 2012) Disulfide-cyclized nona-peptide (CRYPEVEIC)
Binds to the active site of Pin1 (Duncan et al., 2011) 
Covalently modifying small molecule inhibitors
Juglone was the first discovered and most prominent irreversible parvulin inhibitor (Hennig et al., 1998 ). Although juglone is used in many in-vitro (Chao, 2001) but also in cellular studies as Pin1-specific inhibitor Kanaoka et al., 2015; Costantino et al., 2016) , it is certainly not selective in a cellular environment, as its 1,4-naphthoquinone moiety covalently modifies all accessible cytoplasmic cysteine residues available in a cell. This low selectivity of 1,4-naphthoquinone derivatives such as juglone hampers a straightforward correlation between Pin1 inhibition and the physiological outcome observed in cellular and/or animal models, although the physiological effects observed upon inhibitor addition to cells are beyond controversy. Other small molecule inhibitors, introduced in 2003 by Bayer and coworkers, may share this selectivity problem. They demonstrated that the apoptosis of a Ras-transformed cell line can be induced by Pin1 inhibitors designed on the basis of the actinomycete farnesyl transferase inhibitor pepticinnamin C (Bayer et al., 2005) . These inhibitors did not act in the farnesyl transfer pathway but initiated the aggregation of Pin1 by attacking and adding covalently to cysteine and/ or lysine side chains of the protein.
Competitive small molecule inhibitors
In 2003, Uchida and colleagues rationally designed tetraoxobenzo-phenanthroline compounds that competitively blocked Pin1 PPIase activity with low microliter IC 50 values in-vitro and showed inhibiting effects in mouse embryonic fibroblasts (Uchida et al., 2003) . Two years later, dipentamethylene thiuram monosulfide (DTM) as potent inhibitor of Pin1 PPIase activity was identified (Tatara et al., 2009) . DTM is a putative competitor of Pin1 substrates that is capable of inhibiting the proliferation of HCT116 colon carcinoma cells. In addition, synthetic Pin1 directed imidazole and isothiazole derivatives (Mori et al., 2011) and substituted phenyl-imidazoles (Potter et al., 2010) have cytotoxic effects and lead to growth arrest in cancer cells. The polyphenol epigallocatechin-3-gallate (EGCG) inactivates Pin1 by blocking the binding sites for pSer-Pro substrates within the PPIase and the WW-domain (Urusova et al., 2011; Xi et al., 2016) , thereby, preventing tumor growth. Recently, Wei and coworkers proved that all-trans retinoic acid inhibits Pin1 at the proline binding pocket in the catalytic center. It could be used for treatment of acute promyelocytic leukemia in animal models (Wei et al., 2015) .
Small molecule inhibitors with unknown mechanisms
Phlorotannins are natural polyphenols found in heterokonts. Although phlorotannin based Pin1 inhibitors suppress the differentiation of embryonic fibroblasts into adipose cells (Mori et al., 2014) , their molecular action has not been determined so far.
Peptidic inhibitors and substrate analogs
A first comprehensive study on substrate based Pin1 inhibitors revealed an inhibitory potential of L-and DXaa-Pro dipeptides (Zhang et al., 2002) . A few years later, a series of potent phosphorylated pentameric to octameric phosphorylated peptidic inhibitors of Pin1 activity was selected from a combinatorial library (Wildemann et al., 2006a) . These inhibitors contained non-proteogenic amino acids and blocked cell cycle progression in HeLa cells in a dose-dependent manner. In addition, high resolution crystal structures of the D-and L-forms of two of these pentameric inhibitors have been published (Zhang et al., 2007) . In the structure of the L-peptide complex the pThr-Pip (piperidine-2-carboxylic acid) carbonyl group faces away from the side chains of Arg 68 , Gln 131 and Ser 154 , resulting in an ω bond angle close to the cis conformation, whereas in the D-peptide-complex the carbonyl moiety forms a hydrogen bond with the Ser 154 hydroxyl group. Even more potent inhibitors have been synthesized by using cyclization of peptides . The group of Felicia Etzkorn synthesized conformationally locked phosphorylated peptidomimetic inhibitors (Wang et al., 2004) . The cis-isostere inhibits Pin1 more than 20-fold better than the trans-isostere does. By variation of these ground state analogs, the same lab developed phosphorylated transition state inhibitors for Pin1 . Moreover, the Etzkorn group described cyclohexyl ketone Inhibitors of Pin1 that dock in a trans-diaxial conformation to the Pin1 active site in crystal structures (Xu et al., 2012) . The information obtained from these inhibitors verified the twisted-amide mechanism for Pin1 catalysis. Recently, it was demonstrated that a phosphate moiety is dispensable for the creation of high affinity Pin1 peptide inhibitors. By phage panning a disulfide-cyclized nonapeptide has recently been discovered (Duncan et al., 2011) to inhibit Pin1 activity in in-vitro assays by binding to the catalytic site of the PPIase domain.
Outlook
Twenty years after the discovery of human Pin1, the structure, cellular function and catalytic mechanism of the protein seem to be well understood. The ability of regulating protein-phosphorylation dependent cellular events has promoted Pin1 to one of the favored studied proteins in biomedical research. As inhibition of Pin1 induced apoptosis in tumor cell lines, but caused no life-threading effects in Pin1 −/− mice, this human PPIase became of main interest for drug development. In contrast to Pin1 the cellular role of Par14 is largely unknown, although the protein is highly conserved within metazoans and cellular studies discovered a putative cross-talk of Pin1 and Par14. It seems that Par14 parallels some of the functions of Pin1, but the mechanism behind the action of Par14 remains elusive. Particularly, the function of its N-terminal extension has not been targeted by in vivo studies, so far. Despite the biomedical research done on Pin1 and Par14, the function of Par17 is still an enigma, although the essential facts that this isoform is only expressed in hominids might attribute an outstanding importance to the function of Par17 for the evolution of higher primates. Certainly more grounded work is to be done to elucidate the cellular role of Par14 and Par17 in a cellular context as well as their interplay with Pin1 in the near future.
